Ascendis Pharma A (ASND) Goodwill (2015 - 2022)

Ascendis Pharma A has disclosed Goodwill across 8 years of filings, most recently posting $4.9 million for Q4 2022.

• Goodwill for Q4 2022 came in at $4.9 million, down 18.33% year-over-year; the trailing twelve-month figure through Dec 2022 was $4.9 million (down 18.33% YoY), and the FY2022 annual result was $4.9 million, down 18.33% from the prior year.
• Goodwill came in at $4.9 million for Q4 2022 at Ascendis Pharma A, down from $6.0 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $6.8 million in Q4 2020 to a low of $3.9 million in Q4 2019.
• The 5-year median for Goodwill is $4.9 million (2022), against an average of $5.1 million.
• Across the five-year window, Goodwill jumped 76.2% in 2020 and decreased 18.33% in 2022, its largest moves.
• Ascendis Pharma A's Goodwill stood at $4.0 million in 2018, then slipped by 3.02% to $3.9 million in 2019, then surged by 76.2% to $6.8 million in 2020, then declined by 11.52% to $6.0 million in 2021, then fell by 18.33% to $4.9 million in 2022.
• The last three Goodwill figures came in at $4.9 million (Q4 2022), $6.0 million (Q4 2021), and $6.8 million (Q4 2020), per Business Quant data.